Evelo Biosciences, Inc. Contracts & Agreements

Plan of Dissolution of Evelo Biosciences, Inc (Filed With SEC on November 21, 2023)

Letter Agreement with Balkrishan (Simba) Gill, Ph.D., dated August (Filed With SEC on August 21, 2023)

Sublease Termination and Surrender Agreement, executed as of July 14, 2023, by and between Evelo Biosciences, Inc. and Bio-Rad Laboratories, Inc (Filed With SEC on July 20, 2023)

Registration Rights Agreement, dated as of July 11, 2023, by and among Evelo Biosciences, Inc. and the Investors named therein (Filed With SEC on July 12, 2023)

Securities Purchase Agreement, dated as of July 7, 2023, by and among Evelo Biosciences, Inc. and the Investors named therein (Filed With SEC on July 10, 2023)

Waiver and Amendment to Venture Loan and Security Agreement and Eleventh Extension of Standstill Agreement, dated as of July 7, 2023, by and among Evelo Biosciences, Inc., Horizon... (Filed With SEC on July 10, 2023)

Evelo Biosciences, Inc. 2018 Incentive Award Plan, as amended and restated (Filed With SEC on June 8, 2023)

Severance Agreement, dated February 13, 2023, by and between Evelo Biosciences, Inc. and Jonathan Zung (Filed With SEC on March 16, 2023)

Letter Agreement, dated February 1, 2023, by and between Evelo Biosciences, Inc. and Marella Thorell (Filed With SEC on March 16, 2023)

Form of Warrant to Purchase Common Stock, dated as of December 15, 2022, issued by Evelo Biosciences, Inc. to Horizon Technology Finance Corporation, together with a schedule of... (Filed With SEC on December 16, 2022)

Loan and Security Agreement by and among Evelo Biosciences, Inc. and Horizon Technology Finance Corporation, dated December 15, 2022 (Filed With SEC on December 16, 2022)

Amended and Restated Warrant to Purchase Common Stock, dated as of (Filed With SEC on November 14, 2022)

Offer Letter, dated (Filed With SEC on November 14, 2022)

Modification Letter (Filed With SEC on November 14, 2022)

Offer Letter (Filed With SEC on August 11, 2022)

Sales Agreement, dated July 1, 2022, between Evelo Biosciences, Inc. and Cowen and Company, LLC (Filed With SEC on July 1, 2022)

Form of Securities Purchase Agreement, dated May 25, 2022, by and among the Company and the several Purchasers named therein (Filed With SEC on May 25, 2022)

Evelo Biosciences, Inc. Non-Employee Director Compensation Program, as amended, effective April 1, 2022 (Filed With SEC on March 24, 2022)

Patent License Agreement between Mayo Foundation for Medical Education and Research and Evelo Biosciences, Inc., dated August 6, 2017, as amended January 19, 2018 and further... (Filed With SEC on March 24, 2022)

Amendment No. 1 to Clinical Master Services Agreement between Evelo Biosciences, Inc. and Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany, dated February 8, 2022 (Filed With SEC on March 24, 2022)

Employment Agreement of Mark Bodmer by and between Evelo Biosciences (UK) Limited and Mark Bodmer, dated December 31, 2021 (Filed With SEC on January 4, 2022)

Evelo Biosciences, Inc. Non-Employee Director Compensation Program, as amended June 9, 2021 (Filed With SEC on July 29, 2021)

Warrant to Purchase Common Stock, dated as of June 16, 2021, issued by Evelo Biosciences, Inc. to K2 HealthVentures Equity Trust LLC (Filed With SEC on June 17, 2021)

Fourth Amendment, dated of June 16, 2021, to the (Filed With SEC on June 17, 2021)

Amendment No. 2 to Consulting Agreement dated April 9, 2021 between Evelo Biosciences, Inc. and David R. Epstein (Filed With SEC on April 29, 2021)

Amendment dated April 9, 2021 to Letter Agreement between Evelo Biosciences, Inc. and David R. Epstein (Filed With SEC on April 29, 2021)

Commercialization and License Agreement dated March 17, 2021 by and among Evelo Biosciences, Inc. and Meddist Company Limited (Filed With SEC on March 23, 2021)

Development and Clinical Master Services Agreement between Evelo Biosciences, Inc. and Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany dated December 17, 2020 (Filed With SEC on March 9, 2021)

Underwriting Agreement, dated January 28, 2021, by and among the Company and Morgan Stanley & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters... (Filed With SEC on February 2, 2021)

Letter Agreement, dated September 16, 2019, between Evelo Biosciences, Inc. and David R. Epstein, as amended (Filed With SEC on October 30, 2020)

Consulting Agreement, dated September 16, 2019, between Evelo Biosciences, Inc. and David R. Epstein, as amended (Filed With SEC on October 30, 2020)

Third Amendment to Loan and Security Agreement dated as of July 8, 2020 by and among Evelo Biosciences, Inc., the lenders party thereto and K2 HealthVentures LLC, as... (Filed With SEC on July 31, 2020)

Second Amendment to Loan and Security Agreement dated as of May 15, 2020 by and among Evelo Biosciences, Inc., the lenders party thereto and K2 HealthVentures LLC, as... (Filed With SEC on May 18, 2020)

Description of Capital Stock (Filed With SEC on February 14, 2020)

2018 Employee Stock Purchase Plan, as amended (Filed With SEC on February 14, 2020)

Non-Employee Director Compensation Program, as amended (Filed With SEC on February 14, 2020)

Executive Severance Plan, as amended (Filed With SEC on February 14, 2020)

Amendment No. 1 to Exclusivity and Commitment Agreement between Evelo Biosciences, Inc. and Biose Industrie, dated as of August 1, 2019 (Filed With SEC on November 5, 2019)

Letter Agreement, dated September 16, 2019, between Evelo Biosciences, Inc. and David R. Epstein (Filed With SEC on September 18, 2019)

Consulting Agreement, dated September 16, 2019, between Evelo Biosciences, Inc. and David R. Epstein (Filed With SEC on September 18, 2019)

Collaboration Agreement between Evelo Biosciences, Inc. and Sacco S.r.l., dated July 9, 2019 (Filed With SEC on August 6, 2019)

Loan and Security Agreement between Pacific Western Bank and Evelo Biosciences, Inc., dated August 15, 2016, as amended on June 14, 2017, August 18, 2017, February 7, 2018, March... (Filed With SEC on August 6, 2019)

Loan and Security Agreement by and among Evelo Biosciences, Inc. and the other borrowers party thereto, the lenders party thereto, K2 HealthVentures LLC, as administrative agent... (Filed With SEC on August 6, 2019)

Loan and Security Agreement by and among Evelo Biosciences, Inc. and the other borrowers party thereto, the lenders party thereto, K2 HealthVentures LLC, as administrative agent... (Filed With SEC on July 24, 2019)

Loan and Security Agreement between Pacific Western Bank and Evelo Biosciences, Inc., dated August 15, 2016, as amended on June 14, 2017, August 18, 2017, February 7, 2018, March... (Filed With SEC on May 3, 2019)

Terms and Conditions of Employment between Evelo Biosciences (UK) Limited and Duncan McHale, M.B.B.S., Ph.D., effective May 1, 2019 (Filed With SEC on April 25, 2019)

Master Services Agreement, dated September 1, 2018, between Evelo Biosciences, Inc. and Weatherden Ltd (Filed With SEC on February 15, 2019)

Form of Underwriting Agreement (Filed With SEC on April 30, 2018)

Fourth Amended and Restated Investors Rights Agreement, dated February 9, 2018, by and among the Registrant and the investors named therein, as amended on April 30, 2018 (Filed With SEC on April 30, 2018)

Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on April 30, 2018)

2015 Stock Incentive Plan, as amended, and U.K. sub-plan and forms of agreements thereunder (Filed With SEC on April 30, 2018)

2018 Incentive Award Plan (Filed With SEC on April 30, 2018)

2018 Employee Stock Purchase Plan (Filed With SEC on April 30, 2018)

Non-Employee Director Compensation Program (Filed With SEC on April 30, 2018)

Executive Severance Plan (Filed With SEC on April 30, 2018)

Form of Indemnification Agreement for Directors and Officers (Filed With SEC on April 30, 2018)

Sublease Agreement between the Registrant and Bio-Rad Laboratories, Inc., dated December 27, 2017 (Filed With SEC on April 30, 2018)

Terms and Conditions of Employment between the Registrant and Duncan McHale, M.D., Ph.D. (to be effective upon the closing of this offering) (Filed With SEC on April 30, 2018)

Offer Letter between the Registrant and Mark Bodmer, Ph.D., dated October 6, 2015 (Filed With SEC on April 30, 2018)

Offer Letter between the Registrant and Balkrishan (Simba) Gill, Ph.D., dated June 25, 2015, as amended on April 26, 2018 (Filed With SEC on April 30, 2018)

Terms and Conditions of Employment between the Registrant and Duncan McHale, M.D., Ph.D., dated December 15, 2017, as amended on April 16, 2018 (Filed With SEC on April 30, 2018)

Agreement for the Supply of Services, dated January 1, 2017, as amended on July 22, 2017, between the Registrant and Weatherden Ltd (Filed With SEC on April 30, 2018)

Patent License Agreement between Mayo Foundation for Medical Education and Research and the Registrant, dated August 6, 2017 (Filed With SEC on April 30, 2018)

Exclusive License Agreement between The University of Chicago for an Immuno-oncology Technology and the Registrant, dated March 10, 2016 (Filed With SEC on April 30, 2018)

Exclusivity and Commitment Agreement between Biose and the Registrant, dated February 15, 2018 (Filed With SEC on April 30, 2018)

Loan and Security Agreement between Pacific Western Bank and the Registrant, dated August 15, 2016, as amended on June 14, 2017, August 18, 2017 and February 7, 2018 (Filed With SEC on April 30, 2018)

Fourth Amended and Restated Investors Rights Agreement, dated February 9, 2018, by and among the Registrant and the investors named therein (Filed With SEC on April 13, 2018)

Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on April 13, 2018)

Common Stock Purchase Warrant issued to Mayo Foundation for Medical Education and Research, dated June 10, 2016 (Filed With SEC on April 13, 2018)

Warrant to Purchase Stock issued to Comerica Bank, dated November 13, 2015, to purchase Series A preferred stock (Filed With SEC on April 13, 2018)

Amended and Restated Warrant to Purchase Stock issued to Pacific Western Bank, dated August 15, 2016, to purchase Series A-1 preferred stock (Filed With SEC on April 13, 2018)

Warrant to Purchase Stock issued to Pacific Western Bank, dated August 15, 2016, to purchase Series A-3 preferred stock (Filed With SEC on April 13, 2018)

Second Warrant to Purchase Stock issued to Pacific Western Bank, dated February 7, 2018, to purchase Series B preferred stock (Filed With SEC on April 13, 2018)

2015 Stock Incentive Plan, as amended through December 27, 2017, and forms of agreements thereunder (Filed With SEC on April 13, 2018)

Lease between the Registrant and 620 Memorial Leasehold LLC, dated July 14, 2015, as amended on January 24, 2018 (Filed With SEC on April 13, 2018)

Patent License Agreement between Mayo Foundation for Medical Education and Research and the Registrant, dated August 6, 2017 (Filed With SEC on April 13, 2018)

Exclusive License Agreement between The University of Chicago for an Immuno-oncology Technology and the Registrant, dated March 10, 2016 (Filed With SEC on April 13, 2018)

Exclusivity and Commitment Agreement between Biose and the Registrant, dated February 15, 2018 (Filed With SEC on April 13, 2018)

Category

Industry

Companies

Contracts

Evelo Biosciences, Inc. Contracts & Agreements